xbrl.rienks.biz
English 
Nederlands
Français
Deutsch Pharming Group N.V.
| Adresse | Börse | Aktie (18-05-2012: 17:35:00) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
-6.98%Industrie: Gesundheitswesen
Sector: Biotechnologie
Companies engaged in research into and development of biological substances for the purposes of drug discovery and diagnostic development, and which derive the majority of their revenue from either the sale or licensing of these drugs and diagnostic tools.
| Crucell N.V. | (CRXL) | Biotechnologie |
| Fornix BioSciences N.V. | (FORBI) | Biotechnologie |
| Galapagos | (GLPGA) | Biotechnologie |
| Pharming Group N.V. | (PHARM) | Biotechnologie |
Ende Geschäftsjahr: 31-12
| English | Dutch | |
| Annual Report 2007 (6.06 MB) (Ernst & Young) Annual Report 2006 (4.16 MB) (Ernst & Young) Annual Report 2005 (1.96 MB) (Ernst & Young) Annual Report 2004 (1.40 MB) (Ernst & Young) | Jaarverslag 2007 (6.96 MB) (Ernst & Young) Jaarverslag 2006 (3.22 MB) (Ernst & Young) Jaarverslag 2005 (1.97 MB) (Ernst & Young) |
Nachrichten
Unternehmenskalender
| Jahreszahl | Vierteljahresbericht | Investor Relations |
|---|---|---|
| 17-02-2006 | Q1 - | - |
| Q2 04-08-2006 | - | |
| GV | Q3 27-10-2006 | - |
| - | Q4 - | - |
Jahresabschlußes Pharming Group N.V.